In summary, there is clinical evidence that Pso, especially if associated with arthritis and a more advanced age, is associated with hypovitaminosis D, inflammation, and OP, and these factors might shift the effect of IL-33 from osteoprotective to proinflammatory and osteoclastogenic (39). Here, IL33 is linked to Arthritis.